Alibaba AI Allegations: BABA Drops 3% on New Warning

What Do the Alibaba AI Allegations Mean for U.S. Portfolios?

Alibaba Group Holding Limited (BABA) fell to $92.22 in pre-market trading on Friday — down 3.00% from its prior close — as Wall Street digested the implications of Anthropic’s formal complaint. The accusation isn’t theoretical: Anthropic alleges Alibaba-affiliated operators harvested Claude’s most advanced capabilities — including agentic reasoning and software engineering — to accelerate development of its Qwen 3.7 Max model. With Alibaba trading at just 12x forward P/E versus U.S. peers like Meta (30x) and Apple (32x), the valuation gap had already reflected skepticism. Now, the Alibaba AI Allegations are widening it. Analysts at Nomura note the issue is less about immediate litigation risk and more about ‘long-term trust erosion among U.S. institutional investors and partners.’

How Are U.S. Fund Managers Reacting?

Cathie Wood’s ARK Invest sold $16.7 million worth of Alibaba shares across ARKF, ARKK, and ARKW ETFs on Thursday — the largest single-day divestment in over six months. That move coincided with aggressive purchases of Palantir (NASDAQ:PLTR) and Cerebras Systems (NASDAQ:CBRS), both positioned as AI infrastructure beneficiaries in a tightening U.S. export-control environment. Meanwhile, RBC Capital Markets downgraded Alibaba to ‘Underperform’ on June 25, citing ‘unquantifiable geopolitical overhang’ and ‘heightened regulatory scrutiny in both Washington and Brussels.’ The firm cut its 12-month price target to $78, representing 15% downside from current levels. This contrasts sharply with bullish sentiment toward domestic AI enablers: NVIDIA shares rose 2.3% on the same day, supported by renewed data center demand signals.

Is This Just Another Distillation Claim — or a Turning Point?

This isn’t Anthropic’s first distillation allegation — it flagged three Chinese labs in February — but the scale is unprecedented. The 28.8 million exchanges occurred between April 22 and June 5, overlapping with Alibaba’s Q2 2026 AI infrastructure rollout. Crucially, the letter explicitly frames the incident as a national security issue, urging Congress to tighten chip export rules and introduce penalties for AI model theft. That escalation signals a shift from industry dispute to policy battleground. Goldman Sachs analysts warn in a June 25 note that ‘if the Commerce Department initiates a formal investigation, BABA’s U.S. ADR program and cross-border R&D partnerships could face immediate restrictions.’ The Hang Seng Tech Index fell 1.6%, but Alibaba’s 4.4% drop in Hong Kong — and 5% in U.S. pre-market — shows the Alibaba AI Allegations are resonating more deeply than broader market moves.

How Does This Impact the Broader AI Arms Race?

Alibaba’s Qwen 3.7 Max ranks eighth globally, per the Artificial Analysis Intelligence Index — well behind Anthropic’s Claude 4 (1st) and Meta’s Llama 4 (2nd). Yet its rapid ascent has relied on aggressive, opaque training methods. As U.S. lawmakers consider the AI Integrity Act — currently in Senate markup — the Alibaba AI Allegations are becoming a central case study. Meanwhile, Tencent and Baidu have seen their U.S.-listed shares fall 2.1% and 3.4%, respectively, on contagion risk. For investors tracking the S&P 500’s tech-weighted gains, the episode underscores that AI leadership isn’t just about compute or data — it’s about compliance, transparency, and governance. That’s why shares of chipmakers like AMD and NVIDIA continue to outperform Chinese cloud peers: infrastructure is trusted; models are not.